Helius Medical Technologies, Inc. is a neurotechnology company. The Company is engaged in the medical device field focused on neurologic deficits using an orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms and promote neuroplasticity, improving the lives of people dealing with neurologic diseases. The Company’s first commercial product is the Portable Neuromodulation Stimulator (PoNS), is a non-implantable medical device, inclusive of a controller and mouthpiece, which delivers mild electrical stimulation to the surface of the tongue to provide treatment of gait deficit and chronic balance deficit. PoNS Therapy utilizes the PoNS device in conjunction with supervised therapeutic exercise. The PoNS Therapy consists of condition-specific exercises for movement control, including balance and gait training and breathing and awareness training, which are tailored to focus on the individual patient’s functional deficits.
Company codeHSDT
Company nameHelius Medical Technologies Inc
IPO dateJun 27, 2014
Founded at2018
CEOMr. Dane C. Andreeff
Number of employees21
Security typeOrdinary Share
Fiscal year-endJun 27
Address642 Newtown Yardley Road
CityNEWTOWN
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code18940
Phone12159446100
Websitehttps://heliusmedical.com/
Company codeHSDT
IPO dateJun 27, 2014
Founded at2018
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data